Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study of neurotropic viral infection and Tuberculous CNS infection is the comprehensive investigation of CSF PCR arrays (Hybrydiaztion technique,Sybergreen and Taqman real time PCR arrays of CSF ) in suspected cases of viral CNS infection, Tuberculous CNS infection in both AIDS and non AIDS patients.

Patients with clinical viral encephalitis and all meningoencephalitis including all patients with HIV/AIDS CSF and non AIDS will be banked and test for RNA and DNA viral sequence by Real time PCR arrays and IS6110 gene of Mycobacterium tuberculosis. Clinical data and final diagnosis will be used to analyze the result of this PCR arrays technique compared to clinical gold standard criteria.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Tolerability of Rituximab in Neuromyelitis Optica

NCT00501748

Neuromyelitis Optica

COMPLETED PHASE1

Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection

NCT05198661

Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis

RECRUITING NA

Serum Auto-Antibodies in Neurological Diseases

NCT00704626

Multiple Sclerosis Myasthenia Gravis Transverse Myelitis

ENROLLING_BY_INVITATION

A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

NCT03330418

Neuromyelitis Optica Spectrum Disorders

RECRUITING PHASE3

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

NCT00588822

Precancerous Condition

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CNS Viral Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

AIDS PATIENTS

LUMBAR PUNCTURE

Intervention Type OTHER

LUMBAR PUNCTURE FFOR CSF COLLECTION

2

NON-AIDS PATIENTS

LUMBAR PUNCTURE

Intervention Type OTHER

LUMBAR PUNCTURE FFOR CSF COLLECTION

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LUMBAR PUNCTURE

LUMBAR PUNCTURE FFOR CSF COLLECTION

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. AGE MORE THAN 15 YRS
2. ABLE TO INFORM CONSENT BY THEMSELF OR THEIR PARENT
3. SUSPECTED CNS VIRAL INFECTION

Exclusion Criteria

1. UNABLE/CONTRAINDICATED FOR LUMBAR PUNCTURE OR CSF COLLECTION
2. WITHDRAW CONSENT
3. SUSPECTED SEVERE OR VILURENT VIRAL INFECTION SUCH AS H5N1/SARS INFECTION

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No